Nuvoair Series A Funding Reaches $25M To Expand Patient-Centric Care And Clinical Trials Platform
01/19/22, 9:15 AM
Location
bostonMoney raised
$25 million
Round Type
series a
NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a latest round of financing. The investment was led by Hikma Pharmaceuticals' venture capital arm, Hikma Ventures, and is an extension of the Series A round, previously announced in June 2021. Additional participation from a new strategic investor and existing investors brings the total Series A round to $25 million.
Company Info
Location
boston, massachusetts, united states
Additional Info
With offices in Boston, MA, and Stockholm, Sweden, NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. NuvoAir delivers a more continuous, relationship-based, coordinated and human-centric experience to individuals with complex conditions, with an initial focus on respiratory diseases. NuvoAir partners with health plans and risk-bearing providers with the goal to fully align incentives under a value-based care framework.